https://www.cantechletter.com/2026/07/this-analyst-just-raised-his-target-on-mda-space-to-88-00/Cantech Letteren2026-07-15T10:13:46-03:00This analyst just raised his target on MDA Space to $88.00 https://www.cantechletter.com/2026/07/cannara-biotech-is-a-buy-this-analyst-says-2/Cantech Letteren2026-07-15T10:00:12-03:00Cannara Biotech is a buy, this analyst says https://www.cantechletter.com/2026/07/quarterhill-is-a-buy-this-bank-says/Cantech Letteren2026-07-15T09:51:11-03:00Quarterhill is a buy, this bank says https://www.cantechletter.com/2026/07/os-therapies-is-a-buy-this-analyst-says/Cantech Letteren2026-07-15T09:45:32-03:00OS Therapies is a buy, this analyst says https://www.cantechletter.com/2026/07/carrier-connect-data-may-have-transformative-development-this-analyst-says/Cantech Letteren2026-07-14T09:55:02-03:00Carrier Connect Data may have “transformative” development, this analyst says https://www.cantechletter.com/2026/07/desjardins-says-apotex-health-is-a-buy/Cantech Letteren2026-07-14T09:43:40-03:00Desjardins says Apotex Health is a buy https://www.cantechletter.com/2026/07/beacon-raises-price-target-on-firan-to-30-00/Cantech Letteren2026-07-14T09:37:27-03:00Beacon raises price target on Firan to $30.00 https://www.cantechletter.com/2026/07/nvidia-is-still-a-cheap-stock-this-fund-manager-says/Cantech Letteren2026-07-14T09:30:17-03:00Nvidia is still a cheap stock, this fund manager says https://www.cantechletter.com/2026/07/this-analyst-has-a-500-target-on-mastec/Cantech Letteren2026-07-14T09:25:50-03:00This analyst has a $500 target on MasTec